ADNCX
Price
$12.05
Change
-$0.14 (-1.15%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

ADNCX vs RPMGX

Header iconADNCX vs RPMGX Comparison
Open Charts ADNCX vs RPMGXBanner chart's image
American Beacon ARK Transfmt Innov C
Price$12.05
Change-$0.14 (-1.15%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ADNCX vs RPMGX Comparison Chart
Loading...
VS
ADNCX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNCX is a Sell and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. ADNCX (195M). RPMGX pays higher dividends than ADNCX: RPMGX (0.05) vs ADNCX (0.00). ADNCX was incepted earlier than RPMGX: ADNCX (6 years) vs RPMGX (32 years). ADNCX is a more actively managed with annual turnover of: 33.00 vs. RPMGX (21.70). ADNCX has a lower initial minimum investment than RPMGX: ADNCX (1000) vs RPMGX (2500). ADNCX annual gain was more profitable for investors over the last year : 17.79 vs. RPMGX (14.65). RPMGX return over 5 years is better than : 14.51 vs. ADNCX (-28.86).
ADNCXRPMGXADNCX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years32 years-
Gain YTD-11.0049.026-122%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets195M31.4B1%
Annual Yield % from dividends0.000.05-
Returns for 1 year17.7914.65121%
Returns for 3 years-71.59-13.81518%
Returns for 5 years-28.8614.51-199%
Returns for 10 yearsN/A43.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences